Butt, J. H. and McMurray, J. J.V. (2022) Vericiguat, sacubitril/valsartan and more evidence that we are failing our patients. European Journal of Heart Failure, 24(9), pp. 1623-1624. (doi: 10.1002/ejhf.2647) (PMID:35919944)
![[img]](https://eprints.gla.ac.uk/style/images/fileicons/text.png) |
Text
276347.pdf - Accepted Version 1MB |
Abstract
No abstract available.
| Item Type: | Articles (Editorial) |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Butt, Mr Jawad and McMurray, Professor John |
| Authors: | Butt, J. H., and McMurray, J. J.V. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | European Journal of Heart Failure |
| Publisher: | Wiley |
| ISSN: | 1388-9842 |
| ISSN (Online): | 1879-0844 |
| Published Online: | 02 August 2022 |
| Copyright Holders: | Copyright © 2022 European Society of Cardiology |
| First Published: | First published in European Journal of Heart Failure 24(9): 1623-1624 |
| Publisher Policy: | Reproduced in accordance with the publisher copyright policy |
University Staff: Request a correction | Enlighten Editors: Update this record
Altmetric
Altmetric